Developer docs
API playgroundTry for free, no card

Search company profiles

Brust-zentrum

Full company profile

uuid002empk

Namestring
Brust-zentrum
Legal namestring
Affidea brustCare
Company typeenum
Private
Founded yearint
2002
Descriptiontext

Brust-zentrum operates in the market as Affidea brustCare, a specialized breast cancer diagnosis and treatment provider in Switzerland. The legal entity emerged from the combination of Brust-Zentrum Zürich and Plastic Surgery Group and is positioned as the first provider of truly specialized breast cancer care in Switzerland; the company now operates under the Affidea healthcare group as its strategic parent.

The organization runs two physical breast centers serving the German-speaking region (Brust-Zentrum Zürich) and the Italian-speaking region (Affidea brustCare Tessin). Its underlying clinical technology is a multidisciplinary care model that integrates gynecologists, oncologists, radiologists, breast and plastic surgeons, oncology nurses, genetic counselors, and psycho-oncologists, supported by a tumor board for case coordination and an active clinical studies program that has enrolled over 1,000 study patients since 2007. The technology stack is primarily clinical rather than software-based: the digital layer consists of a multilingual website (DE/IT/EN), an online breast cancer self-check tool, a podcast series, and contact/appointment forms. Core offerings span the full patient journey — prevention/early detection, mammography, biopsy, surgery, reconstruction, chemotherapy, radiation, immunotherapy, targeted therapy, anti-hormonal therapy, supportive and complementary medicine, genetic counseling, and expert second opinions. Disclosed quality signals include more than 10,000 primary breast cancer operations performed and a 3% reoperation rate, alongside HI Label (ECC) and DKG Brust plus Senologie certifications.

The business model is fee-for-service healthcare delivery reimbursed through Swiss mandatory health insurance (KVG/HIV) and supplementary insurance; pricing is not publicly disclosed and is determined per treatment plan. Go-to-market relies on an Ärztenetzwerk (referring physician network) for bottom-of-funnel acquisition, a multilingual website and online self-check tool for top-of-funnel demand capture, and direct contact forms for self-serve appointment requests. Customer segments are individual breast cancer patients (primary) and referring physicians (secondary enabler), with no enterprise or B2B contracting layer.

Short descriptiontext

Brust-zentrum, operating as Affidea brustCare, is a Swiss specialized breast cancer diagnosis and treatment provider operating two centers in Zürich and Tessin, delivering multidisciplinary care from screening to reconstruction via Swiss health insurance reimbursement.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersZürich, Switzerland
HQ citystring
Zürich
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
breast cancer treatment, breast cancer diagnosis, mammography screening, oncology services, clinical breast care
Industry4 codes
1Breast Oncology
CodeHLAKAFAJPrimaryYes
2Breast Imaging Centers (Mammography/Tomosynthesis)
CodeHLAFAKADPrimaryNo
3Medical Oncology
CodeHLAKAFABPrimaryNo
4Radiation Oncology
CodeHLAKAFACPrimaryNo
NAICS code1 code
  • Diagnostic Imaging Centers621512
SIC code2 codes
  • Services-Offices & Clinics Of Doctors Of Medicine8011
  • Services-Specialty Outpatient Facilities, Nec8093
Product category
Specialty Oncology / Breast Cancer Care Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Services Revenue
TypeProfessional Services
Description

Fee-for-service healthcare delivery model providing breast cancer screening, diagnosis, and treatment services reimbursed through Swiss health insurance (KVG/HIV) and supplementary insurance. Services include mammography, biopsies, surgeries, chemotherapy, radiation therapy, immunotherapy, targeted therapy, hormonal therapy, breast reconstruction, and supportive care.

affidea-brustcare.ch
2Second Opinion Consultations
TypeProfessional Services
Description

Expert second opinion services for breast cancer diagnosis and treatment planning, offered as a specialized consultation service.

affidea-brustcare.ch
3Genetic Counseling Services
TypeProfessional Services
Description

Genetic risk assessment and counseling for hereditary breast cancer predisposition.

affidea-brustcare.ch
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Brust-zentrum (Affidea brustCare) operates two specialized breast cancer centers in Zürich and Tessin (Switzerland) delivering the complete patient journey from prevention and early detection through diagnosis, multimodal treatment, reconstruction, and aftercare. Core services include mammography, breast biopsy, breast cancer surgery, breast reconstruction, chemotherapy, radiation therapy, immunotherapy, targeted therapy, anti-hormone therapy, genetic counseling, second opinions, tumor board multidisciplinary review, and clinical trial enrollment.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 3% reoperation rate demonstrating high surgical precision and quality outcomes
+2 more records
Product overview1 text field

Affidea brustCare is a specialized breast cancer treatment center network in Switzerland, operating at two locations (Zürich and Tessin). The organization offers a comprehensive, integrated range of breast cancer care services spanning the entire patient journey: from early detection and prevention (Früherkennung), through diagnostic services including mammography and biopsy, to full treatment spectrum including surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, and anti-hormone therapy. The center also provides supportive care, complementary and integrative medicine, genetic counseling, expert second opinions, and access to clinical trials. The organization emerged from the merger of Brust-Zentrum Zürich and Plastic Surgery Group, combining surgical expertise with oncological care in a multi-disciplinary team approach.

Product and service16 records
1Mammografie (Mammography)
CategoryDiagnostic imaging
Description

Mammography screening and diagnostic imaging service for breast cancer detection and assessment, available to patients across the two breast centers in Switzerland.

2Brustbiopsie (Breast Biopsy)
CategoryDiagnostic service
Description

Tissue sampling and pathological examination service used to confirm or rule out breast cancer following suspicious imaging or clinical findings.

3Brustkrebsoperation (Breast Cancer Surgery)
CategorySurgical treatment
Description

Surgical intervention for breast cancer, performed by breast and plastic surgeons as part of the multidisciplinary treatment pathway.

4Brustrekonstruktion (Breast Reconstruction)
CategoryReconstructive surgery
Description

Breast reconstruction surgery performed by plastic surgeons following mastectomy or as part of breast cancer surgical treatment.

5Chemotherapie (Chemotherapy)
CategorySystemic cancer treatment
Description

Chemotherapy treatment delivered to breast cancer patients as part of systemic therapy coordinated by the oncology team.

6Strahlentherapie (Radiation Therapy)
CategoryRadiation oncology
Description

Radiation therapy treatment for breast cancer, coordinated within the multidisciplinary breast cancer care pathway.

7Immuntherapie (Immunotherapy)
CategorySystemic cancer treatment
Description

Immunotherapy treatment offered to breast cancer patients as part of modern systemic therapy options.

8Zielgerichtete Therapie (Targeted Therapy)
CategorySystemic cancer treatment
Description

Targeted therapy treatment tailored to the molecular profile of the patient's breast cancer.

9Antihormontherapie (Anti-Hormone Therapy)
CategorySystemic cancer treatment
Description

Anti-hormone therapy treatment for hormone receptor-positive breast cancer, managed by the oncology team.

10Medikamentöse Therapie (Pharmacological Therapy)
CategorySystemic cancer treatment
Description

Pharmacological drug therapy provided to breast cancer patients as part of their individualized treatment plan.

11Zweitmeinung (Second Opinion)
CategoryAdvisory service
Description

Expert second opinion consultation service for patients seeking confirmation or alternative options for breast cancer diagnosis or treatment recommendations.

12Früherkennung (Early Detection)
CategoryPreventive service
Description

Breast cancer early detection and prevention screening service for asymptomatic and at-risk patients.

13Genetische Beratung (Genetic Counseling)
CategoryAdvisory service
Description

Genetic risk assessment and counseling service for patients with a family history or concern about hereditary breast cancer predisposition.

14Klinische Studien (Clinical Trials)
CategoryClinical research
Description

Clinical trial program providing breast cancer patients with access to innovative and evidence-based treatment approaches.

15Tumorboard Anmeldung (Tumor Board Registration)
CategoryMultidisciplinary consultation
Description

Tumor board case review and registration service providing multidisciplinary specialist discussion for breast cancer diagnosis and treatment planning.

16Brustkrebs Online Check (Online Breast Cancer Check)
CategoryDigital assessment
Description

Online self-assessment tool enabling patients to evaluate breast cancer symptoms and risk factors digitally before requesting an appointment.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
1Ärztenetzwerk (Physician Network)
Strategic tierCoreTypeOthers
Description

Collaborative network of referring physicians and medical specialists across Switzerland, facilitating patient referrals and coordinated multidisciplinary care for breast cancer patients.

affidea-brustcare.ch
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Large German hospital group with multiple sites offering breast surgery, oncology, and reconstructive services; comparable as a broad incumbent operator with adjacent specialty breast services but not exclusively focused on breast oncology.

2European Institute of Oncology (IEO)
TypeDirect peer
Description

Milan-based specialist cancer hospital focused exclusively on oncology, including a dedicated breast cancer program with multidisciplinary care and clinical research; comparable as a European specialized oncology center model.

3Centre du Sein HUG (Hôpitaux Universitaires de Genève)
TypeDirect peer
Description

University hospital breast center in Geneva providing multidisciplinary breast cancer screening, diagnosis, and treatment; comparable as a Romandie-based specialist competitor offering a similar integrated breast care pathway.

4Brustzentrum Universitätsklinikum München (LMU)
TypeDirect peer
Description

University hospital breast center in Munich offering multidisciplinary breast cancer diagnosis, treatment, and clinical trials; comparable as a European university-affiliated specialist breast center with a similar multidisciplinary model.

TypeDirect peer
Description

University hospital breast center in Bern covering central Switzerland with multidisciplinary oncology, surgery, and reconstructive services; comparable as another Swiss university-affiliated specialist breast care provider.

TypeBroad incumbent
Description

One of Europe's largest private hospital groups operating many sites across Germany with breast surgery and oncology offerings; comparable as a broad incumbent providing overlapping breast services at scale but as part of a wider multi-specialty portfolio.

TypeDirect peer
Description

Largest private hospital group in Switzerland with dedicated breast surgery and oncology offerings across multiple cantons; comparable as a private-pay specialist competitor combining surgical, reconstructive, and oncologic breast services in the Swiss market.

TypeBroad incumbent
Description

German private hospital group operating numerous facilities with breast surgery, oncology, and reconstructive offerings; comparable as a broad incumbent providing overlapping breast services within a multi-specialty hospital network.

9Brustzentrum Charité Berlin
TypeDirect peer
Description

Large German university hospital breast center at Charité with multidisciplinary breast oncology, surgery, reconstruction, and clinical trials; comparable as a leading European specialist breast center with similar certifications (DKG) and academic standing.

10Universitätsspital Zürich (USZ) Breast Center
TypeDirect peer
Description

University hospital in Zürich offering a dedicated breast center with multidisciplinary oncology services; directly comparable as a local specialist competitor serving the same catchment area with overlapping surgical, medical oncology, and imaging capabilities.

Market position
Strengths1 record

Each record includes

Headline, Details, Source

Weaknesses1 record

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Brust-zentrum

Specialty Oncology / Breast Cancer Care Servicesbrust-zentrum.ch

Brust-zentrum, operating as Affidea brustCare, is a Swiss specialized breast cancer diagnosis and treatment provider operating two centers in Zürich and Tessin, delivering multidisciplinary care from screening to reconstruction via Swiss health insurance reimbursement.

What Brust-zentrum does

Brust-zentrum operates in the market as Affidea brustCare, a specialized breast cancer diagnosis and treatment provider in Switzerland. The legal entity emerged from the combination of Brust-Zentrum Zürich and Plastic Surgery Group and is positioned as the first provider of truly specialized breast cancer care in Switzerland; the company now operates under the Affidea healthcare group as its strategic parent.

The organization runs two physical breast centers serving the German-speaking region (Brust-Zentrum Zürich) and the Italian-speaking region (Affidea brustCare Tessin). Its underlying clinical technology is a multidisciplinary care model that integrates gynecologists, oncologists, radiologists, breast and plastic surgeons, oncology nurses, genetic counselors, and psycho-oncologists, supported by a tumor board for case coordination and an active clinical studies program that has enrolled over 1,000 study patients since 2007. The technology stack is primarily clinical rather than software-based: the digital layer consists of a multilingual website (DE/IT/EN), an online breast cancer self-check tool, a podcast series, and contact/appointment forms. Core offerings span the full patient journey — prevention/early detection, mammography, biopsy, surgery, reconstruction, chemotherapy, radiation, immunotherapy, targeted therapy, anti-hormonal therapy, supportive and complementary medicine, genetic counseling, and expert second opinions. Disclosed quality signals include more than 10,000 primary breast cancer operations performed and a 3% reoperation rate, alongside HI Label (ECC) and DKG Brust plus Senologie certifications.

The business model is fee-for-service healthcare delivery reimbursed through Swiss mandatory health insurance (KVG/HIV) and supplementary insurance; pricing is not publicly disclosed and is determined per treatment plan. Go-to-market relies on an Ärztenetzwerk (referring physician network) for bottom-of-funnel acquisition, a multilingual website and online self-check tool for top-of-funnel demand capture, and direct contact forms for self-serve appointment requests. Customer segments are individual breast cancer patients (primary) and referring physicians (secondary enabler), with no enterprise or B2B contracting layer.

Brust-zentrum firmographics

Firmographics
Name
Brust-zentrum
Legal name
Affidea brustCare
Website
https://brust-zentrum.ch
Company type
Private
Founded year
2002
Operating status
Operating
Headcount range
51–100 employees
Short description
Brust-zentrum, operating as Affidea brustCare, is a Swiss specialized breast cancer diagnosis and treatment provider operating two centers in Zürich and Tessin, delivering multidisciplinary care from screening to reconstruction via Swiss health insurance reimbursement.
Ownership category
akta.pro rank

Brust-zentrum industry classification

Industry
Product category
Specialty Oncology / Breast Cancer Care Services
NAICS
Diagnostic Imaging Centers (621512)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Specialty Outpatient Facilities, Nec (8093)
akta.pro primary industry
Breast Oncology (HLAKAFAJ)
akta.pro secondary industries
Breast Imaging Centers (Mammography/Tomosynthesis) (HLAFAKAD), Medical Oncology (HLAKAFAB), Radiation Oncology (HLAKAFAC)

Keywords

  • Breast cancer treatment
  • Breast cancer diagnosis
  • Mammography screening
  • Oncology services
  • Clinical breast care

Where Brust-zentrum is headquartered

Location

Headquarters

HQ city
Zürich
HQ country
Switzerland
HQ region
Europe

Offices2 records

Markets served

Brust-zentrum business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Medical Services Revenue: Fee-for-service healthcare delivery model providing breast cancer screening, diagnosis, and treatment services reimbursed through Swiss health insurance (KVG/HIV) and supplementary insurance. Services include mammography, biopsies, surgeries, chemotherapy, radiation therapy, immunotherapy, targeted therapy, hormonal therapy, breast reconstruction, and supportive care.
  2. Second Opinion Consultations: Expert second opinion services for breast cancer diagnosis and treatment planning, offered as a specialized consultation service.
  3. Genetic Counseling Services: Genetic risk assessment and counseling for hereditary breast cancer predisposition.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Brust-zentrum product offering

Product offering

Core offering

Brust-zentrum (Affidea brustCare) operates two specialized breast cancer centers in Zürich and Tessin (Switzerland) delivering the complete patient journey from prevention and early detection through diagnosis, multimodal treatment, reconstruction, and aftercare. Core services include mammography, breast biopsy, breast cancer surgery, breast reconstruction, chemotherapy, radiation therapy, immunotherapy, targeted therapy, anti-hormone therapy, genetic counseling, second opinions, tumor board multidisciplinary review, and clinical trial enrollment.

Product overview

Affidea brustCare is a specialized breast cancer treatment center network in Switzerland, operating at two locations (Zürich and Tessin). The organization offers a comprehensive, integrated range of breast cancer care services spanning the entire patient journey: from early detection and prevention (Früherkennung), through diagnostic services including mammography and biopsy, to full treatment spectrum including surgery, chemotherapy, radiation therapy, immunotherapy, targeted therapy, and anti-hormone therapy. The center also provides supportive care, complementary and integrative medicine, genetic counseling, expert second opinions, and access to clinical trials. The organization emerged from the merger of Brust-Zentrum Zürich and Plastic Surgery Group, combining surgical expertise with oncological care in a multi-disciplinary team approach.

Differentiator

Problem solved

Functional benefit

Products and services

  • Mammografie (Mammography) Mammography screening and diagnostic imaging service for breast cancer detection and assessment, available to patients across the two breast centers in Switzerland.
  • Brustbiopsie (Breast Biopsy) Tissue sampling and pathological examination service used to confirm or rule out breast cancer following suspicious imaging or clinical findings.
  • Brustkrebsoperation (Breast Cancer Surgery) Surgical intervention for breast cancer, performed by breast and plastic surgeons as part of the multidisciplinary treatment pathway.
  • Brustrekonstruktion (Breast Reconstruction) Breast reconstruction surgery performed by plastic surgeons following mastectomy or as part of breast cancer surgical treatment.
  • Chemotherapie (Chemotherapy) Chemotherapy treatment delivered to breast cancer patients as part of systemic therapy coordinated by the oncology team.
  • Strahlentherapie (Radiation Therapy) Radiation therapy treatment for breast cancer, coordinated within the multidisciplinary breast cancer care pathway.
  • Immuntherapie (Immunotherapy) Immunotherapy treatment offered to breast cancer patients as part of modern systemic therapy options.
  • Zielgerichtete Therapie (Targeted Therapy) Targeted therapy treatment tailored to the molecular profile of the patient's breast cancer.
  • Antihormontherapie (Anti-Hormone Therapy) Anti-hormone therapy treatment for hormone receptor-positive breast cancer, managed by the oncology team.
  • Medikamentöse Therapie (Pharmacological Therapy) Pharmacological drug therapy provided to breast cancer patients as part of their individualized treatment plan.
  • Zweitmeinung (Second Opinion) Expert second opinion consultation service for patients seeking confirmation or alternative options for breast cancer diagnosis or treatment recommendations.
  • Früherkennung (Early Detection) Breast cancer early detection and prevention screening service for asymptomatic and at-risk patients.
  • Genetische Beratung (Genetic Counseling) Genetic risk assessment and counseling service for patients with a family history or concern about hereditary breast cancer predisposition.
  • Klinische Studien (Clinical Trials) Clinical trial program providing breast cancer patients with access to innovative and evidence-based treatment approaches.
  • Tumorboard Anmeldung (Tumor Board Registration) Tumor board case review and registration service providing multidisciplinary specialist discussion for breast cancer diagnosis and treatment planning.
  • Brustkrebs Online Check (Online Breast Cancer Check) Online self-assessment tool enabling patients to evaluate breast cancer symptoms and risk factors digitally before requesting an appointment.

Quantifiable outcome

  • 3% reoperation rate demonstrating high surgical precision and quality outcomes
  • +2 more outcomes

Companies that use Brust-zentrum

Customer profile

Segments2 records

Ideal customer profiles2 records

Brust-zentrum technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Brust-zentrum partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Ärztenetzwerk (Physician Network)coreOthersCollaborative network of referring physicians and medical specialists across Switzerland, facilitating patient referrals and coordinated multidisciplinary care for breast cancer patients.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Brust-zentrum competitors and assessment

Company assessment

Broad incumbents

  • Asklepios Kliniken: Large German hospital group with multiple sites offering breast surgery, oncology, and reconstructive services; comparable as a broad incumbent operator with adjacent specialty breast services but not exclusively focused on breast oncology.
  • Helios Kliniken: One of Europe's largest private hospital groups operating many sites across Germany with breast surgery and oncology offerings; comparable as a broad incumbent providing overlapping breast services at scale but as part of a wider multi-specialty portfolio.
  • Sana Kliniken: German private hospital group operating numerous facilities with breast surgery, oncology, and reconstructive offerings; comparable as a broad incumbent providing overlapping breast services within a multi-specialty hospital network.

Direct peers

  • European Institute of Oncology (IEO): Milan-based specialist cancer hospital focused exclusively on oncology, including a dedicated breast cancer program with multidisciplinary care and clinical research; comparable as a European specialized oncology center model.
  • Centre du Sein HUG (Hôpitaux Universitaires de Genève): University hospital breast center in Geneva providing multidisciplinary breast cancer screening, diagnosis, and treatment; comparable as a Romandie-based specialist competitor offering a similar integrated breast care pathway.
  • Brustzentrum Universitätsklinikum München (LMU): University hospital breast center in Munich offering multidisciplinary breast cancer diagnosis, treatment, and clinical trials; comparable as a European university-affiliated specialist breast center with a similar multidisciplinary model.
  • Inselspital Bern Breast Center: University hospital breast center in Bern covering central Switzerland with multidisciplinary oncology, surgery, and reconstructive services; comparable as another Swiss university-affiliated specialist breast care provider.
  • Hirslanden Klinik: Largest private hospital group in Switzerland with dedicated breast surgery and oncology offerings across multiple cantons; comparable as a private-pay specialist competitor combining surgical, reconstructive, and oncologic breast services in the Swiss market.
  • Brustzentrum Charité Berlin: Large German university hospital breast center at Charité with multidisciplinary breast oncology, surgery, reconstruction, and clinical trials; comparable as a leading European specialist breast center with similar certifications (DKG) and academic standing.
  • Universitätsspital Zürich (USZ) Breast Center: University hospital in Zürich offering a dedicated breast center with multidisciplinary oncology services; directly comparable as a local specialist competitor serving the same catchment area with overlapping surgical, medical oncology, and imaging capabilities.

Market position

Strengths1 record

Weaknesses1 record

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Brust-zentrum social profiles

Digital presence

Brust-zentrum compliance and trust

Trust signal

Compliance2 records

Brust-zentrum financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Brust-zentrum leadership team

Management profile

Number of profiles

Brust-zentrum funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Brust-zentrum M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Brust-zentrum

What does Brust-zentrum do?

Brust-zentrum (Affidea brustCare) operates two specialized breast cancer centers in Zürich and Tessin (Switzerland) delivering the complete patient journey from prevention and early detection through diagnosis, multimodal treatment, reconstruction, and aftercare. Core services include mammography, breast biopsy, breast cancer surgery, breast reconstruction, chemotherapy, radiation therapy, immunotherapy, targeted therapy, anti-hormone therapy, genetic counseling, second opinions, tumor board multidisciplinary review, and clinical trial enrollment.

Is Brust-zentrum a public or private company?

Brust-zentrum is a private company. It is classified as corporate owned and is currently operating.

When was Brust-zentrum founded?

Brust-zentrum was founded in 2002. It employs 51 to 100 people.

Where is Brust-zentrum based?

Brust-zentrum is headquartered in Zürich, Switzerland, in the Europe region.

How does Brust-zentrum make money?

Three revenue lines are on record. Medical Services Revenue is the primary driver. The others are second Opinion Consultations and genetic Counseling Services.

Who are Brust-zentrum's main competitors?

Broad incumbents on record are Asklepios Kliniken, Helios Kliniken and Sana Kliniken. Direct peers are European Institute of Oncology (IEO), Centre du Sein HUG (Hôpitaux Universitaires de Genève), Brustzentrum Universitätsklinikum München (LMU), Inselspital Bern Breast Center, Hirslanden Klinik, Brustzentrum Charité Berlin and Universitätsspital Zürich (USZ) Breast Center.

Does Brust-zentrum have an API?

No public API is recorded for Brust-zentrum.

What industry is Brust-zentrum in?

Brust-zentrum's product category is Specialty Oncology / Breast Cancer Care Services. Its primary akta.pro industry code is HLAKAFAJ, Breast Oncology, with a secondary code of HLAFAKAD, Breast Imaging Centers (Mammography/Tomosynthesis). Its NAICS code is 621512 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales